RTGN

RetinalGenix Technologies Inc.. operates in the surgical & medical instruments & apparatus industry. listed on OTC. headquartered in PETALUMA, CA.

RetinalGenix Technologies Inc. (RTGN) is publicly traded on OTC within the Healthcare sector , specifically in the Surgical & Medical Instruments & Apparatus industry. The company is headquartered in PETALUMA, CA.

Business classification: According to SEC filings, RetinalGenix Technologies Inc. falls under SIC code 3841 — Surgical & Medical Instruments & Apparatus. This classification helps investors compare the company against peers in similar regulatory and operational environments.

Sector outlook: Companies in the Healthcare sector typically share exposure to similar macroeconomic factors — interest rates, regulatory shifts, and consumer demand patterns specific to this industry vertical. Investors evaluating RTGN should benchmark against other Healthcare stocks for comparative analysis.

Industry-specific factors: The Surgical & Medical Instruments & Apparatus industry has specific competitive dynamics — market share concentration, supply chain dependencies, and capital intensity that affect valuation. Compare RTGN with peer companies in Surgical & Medical Instruments & Apparatus to assess relative positioning.

Regulatory disclosures: With CIK 0001836295, RetinalGenix Technologies Inc. files mandatory disclosures with the U.S. Securities and Exchange Commission. These include 10-K annual reports, 10-Q quarterly reports, and 8-K material event filings — accessible via the official SEC EDGAR portal for fundamental research.

This page is for educational and research purposes only and does not constitute investment advice. Always conduct independent due diligence and consult a licensed financial advisor before making investment decisions.